Chronic migraine is when a patient experiences a migraine at least 15 days per month.
Approximately 4 million adults experience chronic migraines, and current guidelines recommend both acute and preventative medications for most chronic migraine patients. Available migraine medications are beneficial, but there continues to be a need for more agents to manage and prevent migraines.
The migraine medication pipeline includes some promising medications that show potential to reduce or eliminate the number of days a patient experiences a migraine. Managed care pharmacists are actively engaged in evaluating available data to support decisions concerning access to new therapies that could be included in treatment plans of patients experiencing chronic migraines.
This webinar will explore the challenges of diagnosing and treating chronic migraine and aim to provide an overview of current treatment guidelines, where medications in the pipeline may fit into those guidelines, and provide insight into the managed care considerations for these new therapies.